BIAF
bioAffinity Technologies, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$3.51
−5.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.20x
- Price / sales
- 0.76x
- Price / cash flow
- -0.39x
Enterprise value
- Enterprise value
- $3.5M
- EV / sales
- 0.59x
- EV / EBITDA
- -0.24x
- EV / EBIT
- -0.28x
- Market cap
- $4.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026